Skip to main content
. Author manuscript; available in PMC: 2009 Sep 15.
Published in final edited form as: J Immunol. 2008 Sep 15;181(6):4168–4176. doi: 10.4049/jimmunol.181.6.4168

Figure 6. Protection of μMT mice by transfer of rNP-immune serum requires antibody.

Figure 6

(A) Serum was obtained from rNP/LPS-vaccinated C57BL/6 mice (ν), rNP/LPS-vaccinated AID/μS mice (σ), and LPS-vaccinated C57BL/6 mice (λ) 40 days post-vaccination. 200 μl of serum were transferred to μMT mice 1 day prior to i.n. challenge with 500 EIU influenza PR8. (A) Weight loss was measured daily and relative body weights were determined. Mean ± S.D., 5 mice/group. (B) Viral titers were measured in the lungs of the recipient mice on d10 post- infection.